These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 21339740)
1. Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis. Kim EK; Yun SJ; Ha JM; Kim YW; Jin IH; Yun J; Shin HK; Song SH; Kim JH; Lee JS; Kim CD; Bae SS Oncogene; 2011 Jun; 30(26):2954-63. PubMed ID: 21339740 [TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species and PI3K/Akt signaling in cancer. Jin SY; Lee HS; Kim EK; Ha JM; Kim YW; Bae S Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S34-5. PubMed ID: 26461347 [TBL] [Abstract][Full Text] [Related]
3. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis. Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor I induces proliferation and migration of porcine trophectoderm cells through multiple cell signaling pathways, including protooncogenic protein kinase 1 and mitogen-activated protein kinase. Jeong W; Song G; Bazer FW; Kim J Mol Cell Endocrinol; 2014 Mar; 384(1-2):175-84. PubMed ID: 24508636 [TBL] [Abstract][Full Text] [Related]
5. Differential roles and activation of mammalian target of rapamycin complexes 1 and 2 during cell migration in prostate cancer cells. Venugopal SV; Caggia S; Gambrell-Sanders D; Khan SA Prostate; 2020 Apr; 80(5):412-423. PubMed ID: 31995655 [TBL] [Abstract][Full Text] [Related]
6. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis. Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809 [TBL] [Abstract][Full Text] [Related]
8. Ascofuranone suppresses invasion and F-actin cytoskeleton organization in cancer cells by inhibiting the mTOR complex 1 signaling pathway. Jeong YJ; Hwang SK; Magae J; Chang YC Cell Oncol (Dordr); 2020 Oct; 43(5):793-805. PubMed ID: 32488849 [TBL] [Abstract][Full Text] [Related]
9. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Gulhati P; Bowen KA; Liu J; Stevens PD; Rychahou PG; Chen M; Lee EY; Weiss HL; O'Connor KL; Gao T; Evers BM Cancer Res; 2011 May; 71(9):3246-56. PubMed ID: 21430067 [TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells. Whitley BR; Beaulieu LM; Carter JC; Church FC Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899 [TBL] [Abstract][Full Text] [Related]
11. Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion. Chen L; Xu B; Liu L; Liu C; Luo Y; Chen X; Barzegar M; Chung J; Huang S Oncotarget; 2015 Mar; 6(9):7136-50. PubMed ID: 25762619 [TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1. Ha JM; Yun SJ; Kim YW; Jin SY; Lee HS; Song SH; Shin HK; Bae SS Biochem Biophys Res Commun; 2015 Aug; 464(1):57-62. PubMed ID: 26032503 [TBL] [Abstract][Full Text] [Related]
13. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR. Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640 [TBL] [Abstract][Full Text] [Related]
14. Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition. Han EK; Leverson JD; McGonigal T; Shah OJ; Woods KW; Hunter T; Giranda VL; Luo Y Oncogene; 2007 Aug; 26(38):5655-61. PubMed ID: 17334390 [TBL] [Abstract][Full Text] [Related]
15. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma. Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319 [TBL] [Abstract][Full Text] [Related]
16. P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer. Dillon LM; Bean JR; Yang W; Shee K; Symonds LK; Balko JM; McDonald WH; Liu S; Gonzalez-Angulo AM; Mills GB; Arteaga CL; Miller TW Oncogene; 2015 Jul; 34(30):3968-76. PubMed ID: 25284585 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of mTORC2 activation by the selective agonist of EPAC, 8-CPT-2Me-cAMP, in prostate cancer cells: assembly of a multiprotein signaling complex. Misra UK; Pizzo SV J Cell Biochem; 2012 May; 113(5):1488-500. PubMed ID: 22173835 [TBL] [Abstract][Full Text] [Related]
18. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway. Vo BT; Morton D; Komaragiri S; Millena AC; Leath C; Khan SA Endocrinology; 2013 May; 154(5):1768-79. PubMed ID: 23515290 [TBL] [Abstract][Full Text] [Related]
19. Synergistic induction of cancer cell migration regulated by Gβγ and phosphatidylinositol 3-kinase. Kim EK; Yun SJ; Ha JM; Kim YW; Jin IH; Woo DH; Lee HS; Ha HK; Bae SS Exp Mol Med; 2012 Aug; 44(8):483-91. PubMed ID: 22627809 [TBL] [Abstract][Full Text] [Related]
20. mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis. Morrison MM; Young CD; Wang S; Sobolik T; Sanchez VM; Hicks DJ; Cook RS; Brantley-Sieders DM PLoS Genet; 2015 Jul; 11(7):e1005291. PubMed ID: 26132202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]